Modernization of Reporting for PDMP

PROJECT ABSTRACT

Bureau of Justice Assistance

Fiscal Year (FY) 22 Harold Rogers Prescription Drug Monitoring Program (PDMP) Amount Requested $1,396,640

The purpose of this proposal is to request funding in the amount of $1,396,640 from the FY 22 PDMP to complete enhancements to California’s Controlled Substance Utilization Review and Evaluation System (CURES) through technological upgrades that will improve the CURES’ data collection process, features, and services.  In an effort to improve CURES features and reduce the technical debt that currently exists, an evaluation and feasibility study will be conducted to validate current usage and implementation of the reporting tools in use versus tools available with the current technology in an effort to provide better reports to detect and prevent the diversion and abuse of controlled substances such as opioids, benzodiazepines, and carisoprodols.  Additionally, funding will be used to maintain the data collection services and fund the Statistical Analysis Software (SAS) license and support costs. 

Upon awarding the FY 22 funds to the PDMP, the funding will be utilized for:

Data Collection Services – Funding will be used to finance data collection services.

SAS License and Support – Funding will be used to finance the 2023- 2024 license renewal and maintenance of SAS.

Consultant Resources – Funding will finance consultant resources for system modifications to upgrade CURES features and standards.  Additionally, the California Department of Justice (CA DOJ) will hire consulting companies to do an evaluation and feasibility study on the best reporting and analytic tool for CURES.

PDMP-Related Meetings Attendance – Funding will be used to finance travel for PDMP-related meetings.

The current state reimbursement and other grant funding the CA DOJ receives to operate the CURES does not cover all costs for these efforts.  If this grant is not awarded, CURES must continue to support obsolete standards; consequentially, maintaining the current technical debt imposed by supporting obsolete standards.  Additionally, upgrades to improve CURES will be deferred.  Denial of this proposal adds fiscal burden since the current state reimbursement and other grant funding that the CA DOJ receives to maintain and operate CURES does not cover all these costs.

This proposal would also allow the CA DOJ to further the goals and objectives of the FY 22 PDMP funding.